These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 1741214)

  • 101. Relationship of procollagen type III propeptide-related antigens in serum to somatic growth in healthy children and patients with growth disorders.
    Danne T; Grüters A; Schuppan D; Quantas N; Enders I; Weber B
    J Pediatr; 1989 Feb; 114(2):257-60. PubMed ID: 2915284
    [No Abstract]   [Full Text] [Related]  

  • 102. Moderate deterioration in glucose tolerance during high-dose growth hormone therapy in glucocorticoid-treated patients with juvenile idiopathic arthritis.
    Bismuth E; Chevenne D; Czernichow P; Simon D
    Horm Res Paediatr; 2010; 73(6):465-72. PubMed ID: 20407232
    [TBL] [Abstract][Full Text] [Related]  

  • 103. Metabolic consequences of 5-year growth hormone (GH) therapy in children treated with GH for idiopathic short stature. Genentech Collaborative Study Group.
    Saenger P; Attie KM; DiMartino-Nardi J; Hintz R; Frahm L; Frane JW
    J Clin Endocrinol Metab; 1998 Sep; 83(9):3115-20. PubMed ID: 9745413
    [TBL] [Abstract][Full Text] [Related]  

  • 104. Influence of ethnicity on IGF-I and procollagen III peptide (P-III-P) in elite athletes and its effect on the ability to detect GH abuse.
    Erotokritou-Mulligan I; Bassett EE; Cowan DA; Bartlett C; McHugh C; Sönksen PH; Holt RI;
    Clin Endocrinol (Oxf); 2009 Jan; 70(1):161-8. PubMed ID: 18616716
    [TBL] [Abstract][Full Text] [Related]  

  • 105. Carbohydrate metabolism in children receiving growth hormone for 5 years. Chronic renal insufficiency compared with growth hormone deficiency, Turner syndrome, and idiopathic short stature. Genentech Collaborative Group.
    Saenger P; Attie KM; DiMartino-Nardi J; Fine RN
    Pediatr Nephrol; 1996 Jun; 10(3):261-3. PubMed ID: 8792386
    [TBL] [Abstract][Full Text] [Related]  

  • 106. Response to nutritional and growth hormone treatment in progeria.
    Abdenur JE; Brown WT; Friedman S; Smith M; Lifshitz F
    Metabolism; 1997 Aug; 46(8):851-6. PubMed ID: 9258264
    [TBL] [Abstract][Full Text] [Related]  

  • 107. Effects of exogenous growth hormone administration on dexamethasone-induced growth impairment in adolescent male rats.
    Kim MG; Oh JS; Kim HK; Leem KH
    Exp Ther Med; 2017 Oct; 14(4):3455-3462. PubMed ID: 29042933
    [TBL] [Abstract][Full Text] [Related]  

  • 108. Glucocorticoids and the regulation of growth hormone secretion.
    Mazziotti G; Giustina A
    Nat Rev Endocrinol; 2013 May; 9(5):265-76. PubMed ID: 23381030
    [TBL] [Abstract][Full Text] [Related]  

  • 109. Mineral abnormalities and long-term graft function in pediatric renal transplant recipients: a role for FGF-23?
    Wesseling-Perry K; Tsai EW; Ettenger RB; Jüppner H; Salusky IB
    Nephrol Dial Transplant; 2011 Nov; 26(11):3779-84. PubMed ID: 21441401
    [TBL] [Abstract][Full Text] [Related]  

  • 110. CKD-MBD after kidney transplantation.
    Wesseling-Perry K; Bacchetta J
    Pediatr Nephrol; 2011 Dec; 26(12):2143-51. PubMed ID: 21394466
    [TBL] [Abstract][Full Text] [Related]  

  • 111. EULAR evidence-based recommendations on the management of systemic glucocorticoid therapy in rheumatic diseases.
    Hoes JN; Jacobs JW; Boers M; Boumpas D; Buttgereit F; Caeyers N; Choy EH; Cutolo M; Da Silva JA; Esselens G; Guillevin L; Hafstrom I; Kirwan JR; Rovensky J; Russell A; Saag KG; Svensson B; Westhovens R; Zeidler H; Bijlsma JW
    Ann Rheum Dis; 2007 Dec; 66(12):1560-7. PubMed ID: 17660219
    [TBL] [Abstract][Full Text] [Related]  

  • 112. Spine abnormalities and damage in patients cured from Cushing's disease.
    Faggiano A; Pivonello R; Filippella M; Di Somma C; Orio F; Lombard G; Colao A
    Pituitary; 2001 Aug; 4(3):153-61. PubMed ID: 12138988
    [TBL] [Abstract][Full Text] [Related]  

  • 113. Cyclosporin A therapy in refractory non-infectious childhood uveitis.
    Kilmartin DJ; Forrester JV; Dick AD
    Br J Ophthalmol; 1998 Jul; 82(7):737-42. PubMed ID: 9924362
    [TBL] [Abstract][Full Text] [Related]  

  • 114. The insulin-like growth factor axis and collagen turnover during prednisolone treatment.
    Wolthers OD; Juul A; Hansen M; Müller J; Pedersen S
    Arch Dis Child; 1994 Nov; 71(5):409-13. PubMed ID: 7529981
    [TBL] [Abstract][Full Text] [Related]  

  • 115. Stimulation of collagen synthesis and linear growth by growth hormone in glucocorticoid-treated children.
    Allen DB; Goldberg BD
    Pediatrics; 1992 Mar; 89(3):416-21. PubMed ID: 1741214
    [TBL] [Abstract][Full Text] [Related]  

  • 116. Treatment of glucocorticoid-induced growth suppression with growth hormone. National Cooperative Growth Study.
    Allen DB; Julius JR; Breen TJ; Attie KM
    J Clin Endocrinol Metab; 1998 Aug; 83(8):2824-9. PubMed ID: 9709954
    [TBL] [Abstract][Full Text] [Related]  

  • 117. Serum levels of carboxyterminal propeptide of type I procollagen and pyridinoline crosslinked telopeptide of type I collagen in normal children and children with growth hormone (GH) deficiency during GH therapy.
    Kubo T; Tanaka H; Inoue M; Kanzaki S; Seino Y
    Bone; 1995 Oct; 17(4):397-401. PubMed ID: 8573414
    [TBL] [Abstract][Full Text] [Related]  

  • 118. Serum aminoterminal propeptide of type III procollagen: a potential predictor of the response to growth hormone therapy.
    Tapanainen P; Risteli L; Knip M; Käär ML; Risteli J
    J Clin Endocrinol Metab; 1988 Dec; 67(6):1244-9. PubMed ID: 3192681
    [TBL] [Abstract][Full Text] [Related]  

  • 119. Effects of long-term treatment with growth hormone on bone and mineral metabolism in children with growth hormone deficiency.
    Saggese G; Baroncelli GI; Bertelloni S; Cinquanta L; Di Nero G
    J Pediatr; 1993 Jan; 122(1):37-45. PubMed ID: 8419613
    [TBL] [Abstract][Full Text] [Related]  

  • 120. [Efficacy and safety of recombinant human growth hormone solution in children with growth hormone deficiency in China: a multicenter trial].
    Hou L; Luo XP; Du ML; Ma HM; Gong CX; Li YC; Shen SX; Zhao ZH; Liang L; Dong GP; Yan CY; Du HW
    Zhonghua Er Ke Za Zhi; 2009 Jan; 47(1):48-52. PubMed ID: 19573383
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.